(Q46664849)

24 December 2017

title

Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease (English)

1 reference

24 December 2017

1 reference

Laila R Qadan

1

1 reference

24 December 2017

Adel A Ahmed

2

1 reference

24 December 2017

Hussein A Safar

3

1 reference

24 December 2017

Marzouk A Al-Bader

4

1 reference

24 December 2017

Amr A Ali

5

1 reference

24 December 2017

publication date

2 April 2008

1 reference

24 December 2017

published in

Angiology

1 reference

24 December 2017

volume

59

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

198-202

1 reference

24 December 2017

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Managing risk factors for atherosclerosis in critical limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Intermittent claudication. A risk profile from The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Peripheral vascular disease and hypertension: a forgotten association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Serum uric acid in hypertensive patients with and without peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Hormone replacement therapy and peripheral vascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Evidence-based management of peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Optimal medical management of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319707304582

21 January 2018

Identifiers

DOI

10.1177/0003319707304582

1 reference

24 December 2017

1 reference

24 December 2017